Health And Medicine
-
Two named to National Academies’ advisory board
Vanderbilt University’s Roger D. Cone, Ph.D., and Elizabeth Heitman, Ph.D., have been appointed to the National Academies’ Board on Life Sciences, which advises the government and scientific community on a wide range of topics, from stem cell research to bioterrorism. Read MoreSep 12, 2013
-
Sleep education helps families of children with autism
Parent sleep education is beneficial in improving sleep and aspects of daytime behavior and family functioning in children with autism spectrum disorders (ASD), according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders. Read MoreSep 12, 2013
-
‘Proofreader’ key to coronavirus growth
A coronavirus protein is required for replication of the viral genome and may be a good treatment target for SARS and other diseases caused by coronaviruses. Read MoreSep 12, 2013
-
Sarcoidosis research finds promising oral therapy
VUMC researchers have reported promising results in using oral antimycobacterial therapy to treat chronic cutaneous sarcoidosis, considered by clinicians a difficult illness to effectively control. Read MoreSep 5, 2013
-
Study examines physician behaviors
A study of 381 non-Vanderbilt physicians referred to the Vanderbilt Comprehensive Assessment Program has shown that those referred for mental health, substance abuse and improper sexual boundary issues are less likely to receive a fit for duty recommendation than those referred for disruptive behavior. Read MoreSep 5, 2013
-
Controversial info release aids VUMC bird flu research
Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin. Read MoreSep 5, 2013
-
Basic science training grants hit NIH funding ‘grand slam’
When it comes to government funding of basic science training programs for graduate students and postdoctoral fellows, Vanderbilt University Medical Center hit a grand slam this year, officials said. Read MoreAug 29, 2013
-
Probing intestinal immune cell roles
A new in vitro system will allow investigators to explore how immune system T cells develop specialized functions. Read MoreAug 28, 2013
-
Study examines problem physician behaviors
A study of 381 non-Vanderbilt physicians referred to the Vanderbilt Comprehensive Assessment Program (VCAP) in the Department of Psychiatry has shown that those referred for mental health, substance abuse and improper sexual boundary issues are less likely to receive a fit for duty recommendation than those referred for disruptive behavior. Read MoreAug 27, 2013
-
Tumor factor spurs blood vessel growth
A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies. Read MoreAug 26, 2013
-
Pregnancy promoter and protector
Alkaline phosphatase enzymes appear to play roles in promoting pregnancy and in protecting the uterus from bacterial infection. Read MoreAug 23, 2013
-
Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk
Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows. Read MoreAug 22, 2013
-
VU investigators land ‘bridge grants’ from hematology society
Utpal Davé, M.D., and Sandra Zinkel, M.D., Ph.D., have each received one-year, $100,000 “bridge grants” from the American Society of Hematology (ASH) to support research that has not been funded by the National Institutes of Health (NIH) due to budget cuts. Read MoreAug 22, 2013
-
Overcoming resistance in ovarian cancer
The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments. Read MoreAug 22, 2013
-
$5.2M NIH grant bolsters colorectal cancer research
Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer. Read MoreAug 15, 2013
-
Komen grants bolster breast cancer research
Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research. Read MoreAug 15, 2013
-
Obesity pathway component identified
Vanderbilt University researchers have discovered a new critical component in the obesity pathway. Read MoreAug 15, 2013
-
Researchers track neuron branching’s genetic control switch
In an effort to understand how neurons develop different “architectures,” Vanderbilt developmental biologists have discovered a genetic switch that controls one type of neuron branching in the nematode worm. Read MoreAug 15, 2013
-
Oxidative stress in autism
A biomarker for oxidative stress is elevated in patients with both autism spectrum disorder and gastrointestinal dysfunction, suggesting opportunities for individualized approaches to clinical care. Read MoreAug 14, 2013
-
Noninvasive test detects stomach bug
A noninvasive test can be used to identify the presence of Helicobacter pylori and evaluate its virulence, which will be useful in areas with high rates of H. pylori-associated gastric cancer. Read MoreAug 12, 2013